Distinct apoptotic responses imparted by c-myc and max

Blood

Volumn 92, Issue 3, 1998, Pages 1003-1010

  Nesbit, Chadd E ^b   Fan, Saijun ^b   Zhang, Hong ^b   Prochownik, Edward V ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CHLORMETHINE; CISPLATIN; CYTOKINE; DOXORUBICIN; ETOPOSIDE; GROWTH FACTOR; INTERLEUKIN 3; MYC PROTEIN; PACLITAXEL; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; DRUG SENSITIVITY; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL;

EID: 0032147114     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.3.1003.415a19_1003_1010     Document Type: Article

References (44)

1. Evan GI, Littlewood TD: The role of C-myc in growth. Curr Opin Genet Dev 3:44, 1993
2. Koskinen PJ, Alitalo K: Role of myc amplification and overexpression in cell growth, differentiation and death. Semin Cancer Biol 4:3, 1993
3. Amati B, Land H: Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 4:102, 1994
4. Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennert M: Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos Trans R Soc Lond B Biol Sci 345:269, 1994
5. Askew DS, Ashmun RA, Simmons BC, Cleveland JL: Constitutive c-myc expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and induces apoptosis. Oncogene 6:1915, 1991
6. Evan GI, Wylie AH. Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119, 1992
7. Amati B, Littlewood TD, Evan GI, Land H: The c-myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12:5083, 1993
8. Askew DS, Ihle JN, Cleveland JL: Activation of apoptosis associated with enforced Myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood 82:2079, 1993
9. Hermeking H, Eick D: Mediation of c-Myc induced apoptosis by p53. Science 265:2091, 1994
10. Sakamuro D, Evinev V, Elliott KJ, Showe L, White E, Prendergast GC: c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11:2411, 1995
11. Bissonnette RP, Echevenni F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552, 1992
12. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554, 1992
13. Wagner AJ, Small MB, Hay N: Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 13:2432, 1993
14. Blackwood EM, Eisenman RN: Max: A helix-loop-helix-zipper protein that forms a sequence-specific DNA binding complex with myc. Science 251:1211, 1991
15. Prendergast GC, Lawe D, Ziff EB: Association of myn, the murine homolog of max, with c-myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65:395, 1991
16. Blackwood E, Luscher B, Eisenman RN: Myc and Max associate in vivo. Genes Dev 6:71, 1992
17. Kretzner L, Blackwood EM, Eisenman RN: Transcriptional activities of the Myc and Max proteins in mammalian cells. Curr Top Microbiol Immunol 182:435, 1992
18. Zhang H, Fan S, Prochownik EV: Distinct roles for Max protein isoforms in proliferation and apoptosis. J Biol Chem 272:17416, 1997
19. Greenberger JS, Sakakeeney MA, Humphries RK, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic cell lines. Proc Natl Acad Sci USA 80:2931, 1983
20. Valtieri M, Tweardy DJ, Caracciolo D, Johnson K, Mavilio F, Altmann S, Santoli D, Rovera G: Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunology 138:3829, 1987
21. Zhang J, Alter N, Reed JC, Borner C, Obeid LM, Hannun YA: Bcl-2 interrupts the ce rami de-mediated pathway of cell death. Proc Natl Acad Sci USA 93:5325, 1996
22. Boise LH, Gonzalez-Garcia M, Posteme CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
23. 2+ mobilization through distinct pathways. EMBO 113:1341, 1994
24. Smith MJ, Charron-Prochownik DC, Prochownik EV: The leucine zipper of c-myc is required for inhibition of erythroleukemia differentiation. Mol Cell Biol 10:5333, 1990
25. Langlands K, Prochownik EV: A rapid method for the preparation of yeast lysates that facilitates the immunodetection of rare protein species. Anal Biochem 249:250, 1997
26. Prochownik EV, Kukowska J, Rodgers C: c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol Cell Biol 8:3683, 1988
27. Wall ME: A new look at older drugs in cancer treatment; natural products. Biosci Rep 11:480, 1983
28. Beck WT, Danks MK: Mechanisms of resistance to drugs that inhibit DNA topoisomerases. Semin Cancer Biol 2:235, 1991
29. Pommier Y, Leteutre F, Fesen MR, Fujimori A, Bertrand R, Solary E, Kohlhagen G, Kohn KW: Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest 12:530, 1994
30. Harrington EA, Bennett MR, Fanidi A, Evan GI: c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286, 1994
31. Lotem J, Sachs L: Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and defective myeloid leukemic cells. Cell Growth Differ 4:41, 1993
32. Fan F, El-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW, O'Connor PM: p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54:5824, 1994
33. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266:1821, 1994
34. L can confer a multidrug resistance phenotype. Blood 86:1903, 1995
35. L inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res 56:4743, 1996
36. L and Bcl-2. Blood 88:1576, 1996
37. L overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia cells. Cancer Res 57:1109, 1997
38. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
39. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
40. Sklar MD, Thompson E, Welsh MJ, Liebert M, Harney J, Grossman HB, Smith M, Prochownik EV: Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells. Mol Cell Biol 11:3699, 1991
41. Sklar MD, Prochownik EV: Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc. Cancer Res 51:2118, 1991
42. Hockenbery DM, Oltvai Z, Yin X-M, Millmau CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993
43. Minn AJ, Velez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, Fill M, Thompson CB: Bcl-XL forms an ion channel in synthetic lipid membranes. Nature 385:353, 1997
44. Schendel SL, Xie Z, Montai MO, Matsuyama S, Montai M, Reed JC: Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci USA 94:5113, 1997